kallikrein or its precursors. In this preparation, the kidney releases-kallikrein into the perfusate and into the urine [21. This paper reports the influence of prolonged (3 days) dexamethasone administration on urinary m e i n excretion in man on a normal and on a low sodium intake.
Introduction
We have previously demonstrated that the administration of dexamethasone to normal human beings can induce an acute increase in urinary kallikrein excretion [l], as it does on isolated rat kidneys perfused with a saline solution free of Correspondence: Dr Josh M. Ldpez, Laboratorio de Endocrinologia, Escuela de Medicina, Universidad Catdlica de Chile, Casilla 114-D, Santiago, Chile.
Methods
After admission to a metabolic ward, six subjects received a diet containing 10 mmol of sodiumlday (low sodium diet, LSD). Another six subjects received a diet with 14Ommol of sodiumlday (normal sodium diet, NSD). Potassium intake was fmed for both groups at 60 mmol/day. Meals were given at 08.00, 12.30 and 19.00 hours. Only water was allowed between meals. During the day the subjects were seated, and watched television or read and were free to use a nearby washroom.
Twenty-four-hour sodium excretion equalled sodium intake between the second (in NSD patients) and fourth (in LSD patients) days after admission. When sodium balance was achieved, 24-h urine samples were collected for four consecutive periods starting at 08.00 hours.
Dexamethasone (Organon-R) (0.5 mg) was given orally every 6 h to each subject from days 2 through 4, starting at 06.00 hours. Sodium and potassium concentrations were determined in urine when a daily collection was completed. A portion of the urine was frozen at -22°C for subsequent analysis of kallikrein activity, aldosterone and 17-hydroxycorticosteroids.
Urinary kallikrein activity was determined as previously described [3] , by measuring on the isolated rat uterus the oxytocic effect of kinin liberated from dialysed urine incubated with human low-molecular-weight kininogen in excess for 2 min at 37°C and pH 7.4. Results were expressed in units [ l unit represents the oxytocic effect of purified standard human urinary kallikrein, capable of generating 10 ng of kinin (2 min at pH 7.4 and at 37°C) from purified human kininogen 111. This substrate was prepared by the method of Jacobsen [4] . In our laboratory the kallikrein activity measured by this method has shown to have a good correlation with that measured by radioimmunoassay [2] .
Aldosterone was measured by radioimmunoassay and expressed as pg/24 h [5] , and 17-hydroxycorticosteroids were measured by the method of Silber & Porter [6] . Blood pressure was measured every 8 h manually with a mercury manometer in each subject, after at least 5 min of recumbency throughout the whole observation period.
Analysis of variance was performed by using the EMDO package [7] to evaluate the following sources of variance: subjects, time (dexamethasone) and sodium condition. A P value of less than 0.05 was considered significant. A priori comparison between means was assessed by orthogonal contrast, and a posteriori comparison by Schefe's test [8] .
Results
As shown in Fig. 1 , there was no difference between kallikrein excretion on the normal salt diet and on the low salt diet during the control period (NSD = 182 + 68 units/24 h; LSD = 194 +49 units/24 h; P>O.O5). Dexamethasone produced a significant rise in kallikrein excretion in both groups (Table 1 ) (F3,,,=6.9; P<O.OOl). There was no significant difference in the response to dexamethasone between the groups when the overall effect of dexamethasone was analysed for each group. The mean urinary kallikrein excretion during the control day in LSD and NSD groups (188 ? 40 units/24 h) was less than the mean of urinary kallikrein excretion under the effect of Effect of 3 days of dexamethasone administration on urinary kallikrein excretion in normal subjects on 140 mmol of sodium/day intake ( n = 6 ) or on 10 mmol of sodium/day intake (n = 6 ) . Statistical significance was determined by ANOVA for subjects, time (dexamethasone) and sodium intake as described in the Results section. The mean values for urinary excretion of sodium, potassium, 17-hydroxycorticosteroids, aldosterone and water in both groups are presented in Table 1 . The daily potassium excretion on the control day was significantly higher in the group on LSD than in the NSD group (P< 0.05). Except for this value there was no statistical difference between the groups under the effect of dexamethasone (Fi, , < 1 .O).
Sodium intake did not determine any significant difference on 17-hydroxycorticosteroid excretion between both groups (Fi, lo< 1 .O). However, as expected, dexamethasone produced a marked suppressive effect (F,,=44.8; P<O.OOl) on 1 7-hydroxycorticosteroid excretion.
The mean values of urinary aldosterone were significantly different in both groups (FI, lo= 18.8; P<0.002) during the experiment. On LSD aldosterone showed a persistent decrement, with a significant fall betweenday 1 and day 4 (P<0.05).
Sodium intake did not change water excretion (Fl, lo< 1 .O) . However, dexamethasone did induce an increase in water excretion (Fl,,=7.9; P< 0.01) in both groups as a whole when compared with the control day result. This initial ascent was followed by a significantly decreasing trend towards the end of the study (F1,,=4.1; P< No significant correlation could be established between urinary kallikrein excretion and changes in urinary sodium, potasium, 17-hydroxycorticosteroids, aldosterone or water.
0.05).
Blood pressure did not change in any of the subjects throughout the experiment.
Discussion
Urinary kalligrein excretion on the control day (day l), when sodium balance was achieved, was not significantly different between the groups (Table 1 ). This occurred in spite of substantial differences (P<0.002) in aldosterone excretion determined by the sodium intake conditions. This finding is in accordance with our own previous observations [l] , and with the results reported in dogs by Mills & Newport [9] , but it impugns the report of a direct relationship between aldosterone and urinary kallikrein excretion [lo] .
In our experiment low sodium balance was achieved by dietary manipulation alone. This can be different from experiments in which diuretics are used to induce sodium depletion [lo] . Frusemide itself vigorously increases the release of kallikrein in the isolated rat kidney [2] .
Although sodium state appears to be related to the magnitude of the urinary kallikrein excretion in response to dexamethasone, as shown in Fig. 1 , differences between the groups are not statistically significant (P> 0.05).
On days 2 , 3 and 4 urinary kallikrein excretion presented a similar profie in the groups. It is characterized by a brisk increment on the first day on dexamethasone and a later progressive decrement (Fig. l) , regardless of sodium intake (P< 0.01). The consistent response of urinary kallikrein excretion to dexamethasone suggests that this synthetic steroid can exert a direct action upon the renal kallikrein-kinin system. In this respect, our group has demonstrated that dexamethasone can acutely induce a considerable increase in urinary kallikrein excretion by isolated rat kidney perfused with a kallikrein-free saline solution; the kidney releases kallikrein into the perfusate and into the urine [2] . In addition, binding of dexamethasone to renal tubular receptors has been reported [ l l , 121.
The transient character of this response to dexamethasone, already discussed, could imply a renal escape mechanism involving the renal cells that produce kallikrein.
Since our study was performed in normal subjects we cannot completely rule out that a physiological compensatory mechanism could have operated, counterbalancing the initial dexamethasone-induced kallikrein increase.
In summary, our results show a remarkable stimulatory effect of dexamethasone upon the renal kallikrein-kinin system, which appears to be independent of aldosterone. It represents another example of the close but still obscure relationship between adrenal and steroidal activity and the renal kallikrein-kinin system.
